22nd Century Group, Inc.
(NASDAQ : XXII)

( )
XXII After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -3.21%137.710.0%$884.02m
AMGNAmgen, Inc. -0.57%243.961.5%$794.57m
GILDGilead Sciences, Inc. 0.06%63.221.0%$531.81m
VRTXVertex Pharmaceuticals, Inc. -3.62%252.351.9%$444.70m
REGNRegeneron Pharmaceuticals, Inc. -1.25%659.202.6%$412.80m
ILMNIllumina, Inc. -1.40%239.813.3%$302.05m
NVAXNovavax, Inc. 0.31%52.1175.7%$294.76m
BIIBBiogen, Inc. -3.54%195.711.8%$238.30m
BNTXBioNTech SE -1.72%157.060.0%$213.96m
SNSSSunesis Pharmaceuticals, Inc. -2.86%2.040.7%$142.60m
EXASEXACT Sciences Corp. -3.90%52.0017.7%$139.49m
NKTXNkarta, Inc. -5.29%13.080.0%$101.73m
TECHBio-Techne Corp. -3.22%359.094.5%$98.14m
BMRNBioMarin Pharmaceutical, Inc. -1.19%78.184.2%$97.71m
TXG10X Genomics, Inc. -4.31%47.330.0%$92.15m

Company Profile

22nd Century Group, Inc. is a biotechnology company, which develops disruptive plant-based solutions the for life science, consumer product, and pharmaceutical markets. It focuses on technologies that alter the level of nicotine in tobacco plants and the level of cannabinoids in hemp or cannabis plants through genetic engineering, gene-editing, and modern plant breeding techniques. The company was founded on September 12, 2005 and is headquartered in Buffalo, NY.